Podrobno

Evaluation of endocrine disruptome and virtualToxLab for predicting per- and polyfluoroalkyl substances binding to nuclear receptors
ID Franko, Nina (Avtor), ID Vetrih, Manca (Avtor), ID Sollner Dolenc, Marija (Avtor)

.pdfPDF - Predstavitvena datoteka, prenos (420,08 KB)
MD5: 63C68FE198D2B7594114551C90481AFE
URLURL - Izvorni URL, za dostop obiščite https://www.mdpi.com/2039-4713/15/5/136 Povezava se odpre v novem oknu

Izvleček
This study investigated whether the Endocrine Disruptome and VirtualToxLab in silico platforms are suitable for predicting the endocrine disrupting effects of per- and polyfluoroalkyl substances (PFASs)—in particular, for interactions with oestrogen receptors (ERs) and androgen receptor (AR). Compounds included in the U.S. Environmental Protection Agency’s PFAS working list were analysed with both models, and the results were compared with the available in vitro data regarding their modulation of nuclear receptors. Based on the identified prediction parameters, such as sensitivity, specificity, accuracy, and Mathews’ correlation coefficient, VirtualToxLab was found to be a reliable model for predicting the reactivity of PFASs with AR, while a positive consensus approach of both platforms provided reliable predictions of the PFAS reactivity with ERα and ERβ. This study provides the evidence that Endocrine Disruptome and VirtualToxLab can be used as a tier 1 screening tool for assessment of the endocrine disrupting effect of PFASs. Furthermore, it demonstrates that the likelihood of endocrine disrupting properties increases with the lipophilicity of PFASs and identifies the understudied PFHpS, PFNS, PFDS, 9-Cl, NMeFOSAA, NEtFOSAA, 4:2 FTS, 6:2 FTS, 8:2 FTS, 6:2 monoPAP, 8:2 monoPAP, and 5:3 acid as potential ligands of AR and/or ERs.

Jezik:Angleški jezik
Ključne besede:PFAS, endocrine disruptome, VirtualToxLab, endocrine disruption, androgen receptor, estrogen receptor, glucocorticoid receptor, in silico, new approach methods, hormonski motilci, imunomodulacija
Vrsta gradiva:Članek v reviji
Tipologija:1.01 - Izvirni znanstveni članek
Organizacija:FFA - Fakulteta za farmacijo
Status publikacije:Objavljeno
Različica publikacije:Objavljena publikacija
Leto izida:2025
Št. strani:21 str.
Številčenje:Vol. 15, iss. 5, [article no.] 136
PID:20.500.12556/RUL-171388 Povezava se odpre v novem oknu
UDK:616.4
ISSN pri članku:2039-4713
DOI:10.3390/jox15050136 Povezava se odpre v novem oknu
COBISS.SI-ID:246382595 Povezava se odpre v novem oknu
Datum objave v RUL:25.08.2025
Število ogledov:171
Število prenosov:54
Metapodatki:XML DC-XML DC-RDF
:
Kopiraj citat
Objavi na:Bookmark and Share

Gradivo je del revije

Naslov:Journal of xenobiotics
Skrajšan naslov:J. xenobiotics
Založnik:PagePress Publications
ISSN:2039-4713
COBISS.SI-ID:520181017 Povezava se odpre v novem oknu

Licence

Licenca:CC BY 4.0, Creative Commons Priznanje avtorstva 4.0 Mednarodna
Povezava:http://creativecommons.org/licenses/by/4.0/deed.sl
Opis:To je standardna licenca Creative Commons, ki daje uporabnikom največ možnosti za nadaljnjo uporabo dela, pri čemer morajo navesti avtorja.

Sekundarni jezik

Jezik:Slovenski jezik
Ključne besede:PFAS, endokrine motnje, VirtualToxLab, endokrine motnje, androgeni receptor, estrogenski receptor, glukokortikoidni receptor, in silico, nove metode pristopa

Projekti

Financer:ARIS - Javna agencija za znanstvenoraziskovalno in inovacijsko dejavnost Republike Slovenije
Številka projekta:P1-0208
Naslov:Farmacevtska kemija: načrtovanje, sinteza in vrednotenje učinkovin

Podobna dela

Podobna dela v RUL:
Podobna dela v drugih slovenskih zbirkah:

Nazaj